Printer Friendly

UNISURGE NAMES VP-FINANCE, CFO

 CUPERTINO, Calif., May 27 /PRNewswire/ -- Unisurge Inc., a manufacturer and marketer of surgical instruments for laparoscopic surgery, today announced that it named Linda Parinella O'Keefe as vice president of finance and chief financial officer.
 Bringing nearly 15 years experience in financial administration and treasury management, largely in the biopharmaceutical and medical device industries, O'Keefe was previously vice president of financial administration at Genelabs Technologies Inc., of Redwood, Calif.
 "We welcome Linda O'Keefe's decision to join Unisurge," said Robert D. Berkowitz, president and chief executive officer of Unisurge," said Robert D. Berkowitz, president and chief executive officer of Unisurge. "Her expertise and broad experience in financial management and successful completion of private and public corporate financings will be key assets to our business strategy."
 O'Keefe joined Genelabs Technologies in January 1990, where she had responsibility for planning and implementing financial policies and procedures in the areas of financial management, funding, control, planning and analysis and investor relations. In June 1991, she directed the company's initial public offering with proceeds of $25 million after completion of a $7.5 million private financing in March 1991 with a key institutional investor. In addition, she helped to negotiate corporate collaborations with Abbott Laboratories and SmithKline Beecham, each completed with $4.5 million equity components.
 Prior to Genelabs, O'Keefe was vice president of finance at Target Therapeutics Inc., a joint venture originally formed in 1985 by Collagen Corp. and Eli Lilly and Co., which was subsequently acquired by Collagen in 1988. In addition to being responsible for implementing all financial policies and procedures, she developed the company's business plan and completed a financing of $550,000 with investors outside of Collagen.
 Before joining Target Therapeutics, O'Keefe was controller for eight years at Collagen Corp. and was a senior staff member of Arthur Young & Co. (now Ernst and Young) in San Francisco. Licensed as a certified public accountant by the State of California, she received a bachelor of business degree from the University of California, Berkeley.
 Based in Cupertino, Unisurge Inc. was founded in 1990 to develop, manufacture and market surgical instruments for laparoscopic surgery -- a new, less invasive form of abdominal surgery. For sale to general surgeons and operating room nurses, the company's instruments are available as pre-packaged sterilized kits or as individual tools for specific surgical procedures. Unisystem(TM), UniGrip(TM) and Unitip(TM) are trade marks of Unisurge Inc.
 -0- 5/27/93
 /CONTACT: Robert D. Berkowitz, president and CEO of Unisurge, 408-996-4700; or Charles Versaggi of Gable/Versaggi Biocommunications, 408-358-4162, for Unisurge/


CO: Unisurge Inc. ST: California IN: MTC SU: PER

JL-LS -- SD001 -- 2761 05/27/93 08:02 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:May 27, 1993
Words:438
Previous Article:GASOLINE ADDITIVES TO KEEP ENGINES CLEANER
Next Article:MAGMA POWER COMPANY FILES REGISTRATION STATEMENT COVERING A SECONDARY OFFERING OF 5.5 MILLION SHARES OF COMMON STOCK
Topics:


Related Articles
UNISURGE COMPLETES SECOND ROUND OF FINANCING
SYNTEX EXECUTIVE JOINS UNISURGE'S BOARD OF DIRECTORS
UNISURGE COMPLETES THIRD ROUND OF FINANCING
Names in the News.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters